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Catechol-O-methyltransferase Val108/158Met gene and
alcoholism in Turkish subjects
Ayşe Ender ALTINTOPRAK1, Bülent KAYAHAN1, Burçin TEZCANLI2, Buket KOSOVA2,
Hakan COŞKUNOL1

Aim: To determine if the functional Val108/158Met polymorphism causes a tendency toward alcohol addiction in
Turkish cases. This polymorphism of the catechol-O-methyltransferase (COMT) gene has been associated with many
psychiatric disorders, as well as with alcoholism.
Materials and methods: The allele and genotype associations of the Val108/158Met polymorphism in 110 Turkish
alcoholics and 330 healthy subjects were investigated, constituting our study and control groups, by polymerase chain
reaction-restriction fragment length polymorphism.
Results: Distribution of the Met/Met genotype was 16.4% to 20.6% and frequency of the Met allele was 36.8% to 39.5%
in the study group compared to the control group. The results did not show any significant differences in the genotype
distribution and allele frequencies of the polymorphism, neither between the study and the control groups (c2 = 0.985,
P = 0.611 and c2 = 0.517, P = 0.472) nor between female (c2 = 0.247, P = 0.884 and c2 = 0.115, P = 0.735, respectively)
and male (c2 = 0.728, P = 0.695 and c2 = 0.485, P = 0.486, respectively) alcoholics. The power of the study for genotype
analysis was set at 79.1%.
Conclusion: The present study shows that the polymorphic Met allele of the COMT polymorphism is not associated
with alcoholism in Turkish cases; however, due to the lack of statistical power, this research should be evaluated again
with an enlarged study group to confirm the possible association between the polymorphism and alcoholism.
Key words: Alcoholism, catechol-O-methyltransferase, COMT Val108/158Met, polymorphism

Türk olgularda katekol-O-metiltransferaz Val108/158Met gen polimorfizmi ve
alkolizm
Amaç: Fonksiyonel Val108/158Met polimorfizminin Türk olgularda alkol bağımlılığına yatkınlık sağlayıp sağlamadığını
belirlemek. Katekol-O-metiltransferaz (COMT) geninin bu polimorfizmi, alkolizm de dahil olmak üzere pek çok
psikiyatrik hastalık ile ilişkilendirilmiştir.
Yöntem ve gereç: Çalışma ve kontrol gruplarını oluşturan 110 Türk alkol bağımlısı olgu ve 330 sağlıklı bireyde,
Val108/158Met polimorfizminin genotip ve alel ilişkisi PCR-RFLP yöntemiyle incelenmiştir.
Bulgular: Çalışma grubu kontrol grubuyla kıyaslandığında; Met/Met genotipinin dağılımı % 16,4’ e % 20,6 iken, Met
alelinin sıklığı % 36,8’ e % 39,5 olarak bulunmuştur. Sonuçlarımıza göre, genotip dağılımı ve alel sıklığı açısından
çalışma ve kontrol grupları arasında (c2 = 0,985, P = 0,611 ve c2 = 0,517, P = 0,472) ve alkol bağımlısı kadın (c2= 0,247,
P = 0,884 ve c2 = 0,115, P = 0,735 sırasıyla) alkol bağımlısı erkek (c2 = 0,728, P = 0,695 ve c2 = 0,485, P = 0,486 sırasıyla)
arasında anlamlı bir fark saptanmamıştır. Çalışmanın gücü genotip analizi açısından % 79,1 olarak hesaplanmıştır.
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Sonuç: Bu çalışma her ne kadar COMT geni polimorfik Met alelinin Türk olgularda alkolizmle ilişkisi olmadığını
göstersede; istatistiki güç analizinin düşük olması nedeniyle araştırma daha geniş bir çalışma grubuyla tekrar
değerlendirilmelidir böylelikle alkolizm ile polimorfizm arasındaki olası asosiasyon doğrulanabilecektir.
Anahtar sözcükler: Alkolizm, katekol-O-metiltransferaz, COMT Val108/158Met, polimorfizm

Introduction
Alcohol addiction or alcoholism is a multifactorial
disease with genetic and environmental factors
involved in its etiology. The genetic factors playing a role
in the development of alcoholism have been reported
from family, twin, and child adaptation studies, and
molecular studies (1,2). Although the mechanisms
of the genetic transmissions and its pathophysiology
have not been completely understood and solved, it
is certain that many neurotransmitter systems play
a role in the pathophysiology of alcoholism (3). For
alcohol-seeking behavior, it has been shown that
the synthesis and metabolism of dopamine in the
mesolimbic/mesocortical awarding system of the
brain and the amount of active dopamine receptors
have an important impact on ethanol-reinforced
responding (4). The psychological calming effects
of alcohol are achieved by the rapid dopamine
release from the brain’s limbic system after alcohol
consumption (3). Consequently, changes in the
enzymes involved in the synthesis and metabolism of
dopamine, and components of the receptor systems,
have been the focus of investigations of addiction.
The catechol-O-methyltransferase (COMT)
enzyme plays an important role in the inactivation
of epinephrine and norepinephrine, and also in
the inactivation of dopamine (5). In a common
functional polymorphism of the COMT gene, a
valine amino acid at codon 108/158 is changed to
methionine, which results in a 3- to 4-fold loss of
enzyme activity (6-8). In relation to alcoholism, it is
known that individuals with a low-activity COMT
variant metabolize high amounts of dopamine, which
is rapidly released from the limbic region after alcohol
consumption, more slowly than individuals with a
high-activity COMT variant, and are therefore more
exposed to the pleasurable effects of dopamine (5).
This mechanism might account for the predisposition
of some individuals to alcohol abuse.
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This common and functional Val108/158Met
COMT polymorphism has been investigated in
relationship with many disorders, like velocardiofacial
syndrome (9), rapid cycling bipolar disorder (10,11),
schizoaffective and schizophrenic disorders (7,12),
and obsessive-compulsive disorder (13). In these
studies, an association, and also a lack of association,
between the COMT Val108/158Met polymorphism
and the studied psychiatric disorders were found.
In studies in which the relationship between
the COMT Val108/158Met polymorphism and
alcoholism was analyzed, different results were
obtained according to differences in the included
study groups. In some studies, no association
between the COMT Val108/158Met polymorphism
and alcoholism was found (2,14,15). In a study
where the weekly alcohol consumption of social
male drinkers was investigated in association with
the COMT Val108/158Met polymorphism, it was
shown that individuals carrying the COMT genotype
responsible for low enzyme activity consumed more
alcohol during the week (16). Type 1 alcoholism,
which is more frequently observed in the population
and starts after the age of 25 without antisocial
behavior, has also been associated with the COMT
genotype responsible for low enzyme activity
(5,17). However, for type 2 alcoholism, which is
less frequently observed in the population, starts
before the age of 25, and is usually accompanied
with antisocial behavior, contradictory results have
been obtained related to the association between
the COMT genotype, responsible for low enzyme
activity, and alcoholism (2,17-19). Since there is
still much controversy over the studies investigating
the association of the COMT Val108/158Met gene
polymorphism with alcoholism, this study aimed
to address this issue further with Turkish alcoholics
and to investigate whether sex and ethnic differences
might play a role in the association between the
COMT Val108/158Met gene polymorphism and
alcoholism.
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Materials and methods
The study group included 110 unrelated subjects (100
men, 46 ± 9.28 years, and 10 women, 36 ± 7.77 years)
who were assessed by a structured clinical interview
(SCID) for Axis I of the Diagnostic and Statistical
Manual of Mental Disorders (DSM-IV) (American
Psychiatric Association, 1994) by a psychiatrist; all
of the subjects met the DSM-IV diagnostic criteria
for alcohol dependence and none had comorbid
psychiatric disorders. All subjects were chosen from
among 680 people who applied to the Ege University
Medical Faculty Psychiatry Department’s Addiction
Center from the Aegean region of Turkey between
2005 and 2010, and who interviewed with a psychiatrist
for the cure of alcoholism. Alcohol consumption
severity was assessed through 22 questions from
the Michigan Alcohol Screening Test (MAST). The
MAST is widely used in order to determine alcohol
abuse disorders (20). Sociodemographic data (age,
marital status, and level of education) and previous
personal and familial psychiatric history, personal
drug use (including nicotine), and legal problems
were recorded.
The control group consisted of 330 unrelated
healthy subjects (229 men, 44.51 ± 14.23 years, and
101 women, 36 ± 7.45 years). All of the control group
subjects were selected from the same Aegean region
of Turkey as the study group subjects, and they were
evaluated as physically and mentally healthy by a
psychiatrist according to the SCID nonpatient form.
The study design adhered to the Declaration of
Helsinki and was approved by the Ege University
Medical Faculty Ethical Committee prior to the
study’s initiation. Signed consent forms were collected
from all of the study participants. No relationship
existed between any of the subjects in the study and
the control groups.
Genotype analysis of the COMT Val108/158Met
polymorphism (rs 4680)
From each of the 440 participants, 3 mL of peripheral
venous blood was collected into tubes containing
ethylenediaminetetraacetic acid (EDTA), and
genomic DNA was isolated according to the protocols
of the High Pure PCR Template Preparation Kit (Roche
Applied Science, Germany). A 203-bp fragment of
the COMT gene harboring the polymorphic site of

interest was amplified using the following primer
pair: forward 5’-CTCATCACCATCGAGATCAA-3’
and reverse 5’-GATGACCCTGGTGATAGTGG-3’.
The polymerase chain reaction (PCR) reaction mix
contained 25 mM MgCl2, 100 μM of each primer,
2 mM dNTP mix, 10× PCR buffer, 1 U Taq DNA
polymerase, and 50 nmol of genomic DNA. The PCR
conditions were set as 1 min of initial denaturation
at 94 °C followed by 40 cycles of 20 s of denaturation
at 94 °C, 30 s of annealing at 56 °C and 30 s of
elongation at 72 °C, and a final extension of 7 min at
72 °C. The resulting PCR product was purified from
the undesired small side products (<100 bp) using
the High Pure PCR Product Purification Kit. From
the purified PCR product, 10 μL was digested with
1 U NlaIII (Hin1II, Fermentas) for 4 h at 37 °C and
analyzed after running on a 12% polyacrylamide gel
(29:1) stained with ethidium bromide (EtBr). The
presence of guanine nucleotide at codon 108/158
(GTG/Val/high COMT enzyme activity) resulted in
3 fragments of 87 bp, 62 bp, and 54 bp after digestion.
However, when an adenine nucleotide was present
at the same codon instead (ATG/Met/low COMT
enzyme activity), 4 fragments of 69 bp, 62 bp, 54 bp,
and 18 bp were observed. The results were duplicated
by studying the same samples with an electrochemical
biosensor system described elsewhere (21).
Statistical analysis
Allele and genotype frequencies were compared
among the study and control subjects using the chisquare and ANOVA tests. P < 0.05 was considered
statistically significant and the results were evaluated
with SPSS 11.0 for Windows. Power analysis of the
genotype distribution was performed with the NCSSPASS 2000 program; the power calculated for α was
set at 0.05. The study group subjects were consistent
with the Hardy-Weinberg equilibrium (c2 = 0.160, P
= 0.205), whereas the control group subjects were not
(c2 = 14.24, P = 0.001).
Results
Distribution of the wild-type Val/Val genotype in
the study group was 42.7%, of the heterozygote Val/
Met genotype 40.9%, and of the polymorphic Met/
Met genotype 16.4%, whereas their distributions in
the control group were 41.5%, 37.9%, and 20.6%,
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respectively. The frequency of the polymorphic Met
allele was 36.8% in the study group, whereas it was
39.5% in the control group. When the frequency of
the COMT 108/158 Met genotypes (c2 = 0.985, P =
0.611) or alleles (c2 = 0.517, P = 0.472) were compared,
no significant difference was found between the 2
groups. There was also no significant difference in
the genotype and allele frequencies of the COMT
Val108/158Met polymorphism between the female
control and the female alcoholic groups (c2 = 0.115,
P = 0.735 and c2 = 0.247, P = 0.884, respectively) or
between the male control and the male alcoholic
groups (c2 = 0.485, P = 0.486 and c2 = 0.728, P =
0.695, respectively). This distribution is summarized
in Table 1. According to the genotype frequencies,
this study lacks statistical power with 79.1% due to
the smallness of study and control groups, giving rise
to the conclusion that these results do not confirm
the possible association between COMT 108/158
Met variants and alcoholism.
Social backgrounds such as education, occupation,
and marital status of the study group among the 3
subgroups of the COMT genotype are summarized
in Table 2. No significant differences were observed
in any items among these 3 subgroups in the female
and male alcoholic subjects. Age at onset of habitual
and pathological drinking and admission to alcohol
treatment among the 3 subgroups of the COMT
genotype are shown in Table 3. According to the
results, both male and female alcoholics started to
use alcohol habitually at an early age, starting from
15 years of age, and were addicted by the time they
were 25-30 years of age; starting therapy was timeconsuming for them. Comparisons of variables on

alcohol consumption such as drinking amount and
frequency among the 3 subgroups of the COMT
genotype in the female and male alcoholic subjects
are given in Table 4. According to the results, 68.2%
(75 of 110) of the subjects drink more than 10 units
of alcohol and 96.4% (106 of 110) drink every day.
However, in the genotype analyses, no significant
differences were observed among these 3 subgroups
in any of the study group subjects. Finally, smoking/
drug abuse and family history of psychiatric disorders,
alcohol dependence, and drug abuse among the 3
subgroups of the COMT genotype in the study group
are given in Table 5. The results show that while
88.2% (97 of 110) of the alcoholics are smokers, 8.2%
(9 of 110) use both drugs and cigarettes. When the
results were evaluated for family history, most of the
subjects had no relatives with psychiatric disorders
(87.3%, 96 of 110), but for alcoholism, while 36.4%
(40 of 110) of the patients had no family history,
63.6% (70 of 110) had either a first- or second-degree
alcoholic relative or had observed alcoholism in
many family members. However, 91.8% (101 of 110)
of the cases had no family history of drug abuse.
Moreover, no significant differences were observed in
any items among these subgroups in the female and
male alcoholic subjects.
Discussion
The results showed that there were no significant
differences in the frequency of the Met or Val allele,
or the Val/Val, Val/Met, or Met/Met genotypes of
the COMT Val108/158Met polymorphism between
alcoholics and healthy groups. However, it should be

Table 1. Genotype distributions and allele frequencies of the COMT Val108/158Met polymorphism in the study and control groups.

Groups

Genotype

Allele frequencies

P

Val/Val

Val/Met

Met/Met

Val

Met

Study (n = 110)

47 (42.7%)

45 (40.9%)

18 (16.4%)

139 (63.2%)

81 (36.8%)

0.611

Female (n = 10)

3 (30.0%)

5 (50.0%)

2 (20.0%)

11 (55.0%)

9 (45.0%)

0.884

Male (n = 100)

44 (44.0%)

40 (40.0%)

16 (16.0%)

128 (64.0%)

72 (36.0%)

0.695

Control (n = 330 )

137 (41.5%)

125 (37.9%)

68 (20.6%)

399 (60.5%)

261 (39.5%)

0.472

Female (n = 101)

40 (39.6%)

39 (38.6%)

22 (21.8%)

119 (58.9%)

83 (41.1%)

0.735

Male (n = 229)

97 (42.4%)

86 (37.6%)

46 (20.0%)

280 (61.1%)

178 (39.9%)

0.486
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Table 2. Comparisons of variables of social backgrounds among the 3 subgroups of the COMT genotype in female and male alcoholic
subjects (*not available for statistical analyses).
Female alcoholics (N = 10)

Male alcoholics (N = 100)

COMT genotype

COMT genotype

Variables

P
Val/Val
(N = 3)
n (%)

Val/Met
(N = 5)
n (%)

Met/Met
(N = 2)
n (%)

Elementary (n = 42)

1 (33.3%)

2 (66.7%)

0 (0%)

High school (n = 40)

1 (16.7%)

3 (50.0%)

University (n = 28)

1 (100.0%)

P
Val/Val
(N = 44)
n (%)

Val/Met
(N = 40)
n (%)

Met/Met
(N = 16)
n (%)

*

19 (48.8%)

13 (33.3%)

7 (17.9%)

0.214

2 (33.3%)

0.521

12 (35.3%)

17 (50.0%)

5 (14.7%)

0.321

0 (0%)

0 (0%)

*

13 (48.2%)

10 (37.0%)

4 (14.8%)

0.256

0 (0%)

3 (75.0%)

1 (25.0%)

0.548

3 (50.0%)

3 (50.0%)

0 (0%)

0.526

Official (n = 24)

1 (100.0%)

0 (0%)

0 (0%)

*

13 (56.5%)

9 (39.1%)

1 (4.3%)

0.358

Retired (n = 36)

0 (0%)

1 100.0%)

0 (0%)

*

13 (37.2%)

16 (45.7%)

6 (17.1%)

0.369

Employee (n = 11)

1 (50.0%)

1 (50.0%)

0 (0%)

*

5 (55.6%)

2 (22.2%)

2 (22.2%)

0.412

Others (n = 29)

1 (50.0%)

0 (0%)

1 (50.0%)

*

10 (37.0%)

10 (37.0%)

7 (26.0%)

0.453

Married (n = 75)

2 (40.0%)

1 (20.0%)

2 (40.0%)

0.624

34 (48.6%)

26 (37.1%)

10 14.3%)

0.185

Divorced (n = 20)

0 (0%)

2(100.0%)

0 (0%)

*

7 (38.9%)

7 (38.9%)

4 (22.2%)

0.524

1 (33.3%)

2 (66.7%)

0 (0%)

*

3 (25.0%)

7 (58.3%)

2 (16.7%)

0.412

Educational status

Occupational status
None (n = 10)

Marital status

Single (n = 15)

Table 3. Comparisons of variables of age among the 3 subgroups of the COMT genotype in female and male alcoholic subjects.

Variables of age (years)

Female alcoholics (N = 10)

Male alcoholics (N = 100)

COMT genotype

COMT genotype

Val/Val
(N = 3)

Val/Met
(N = 5)

Met/Met
(N = 2)

Val/Val
(N = 44)

Val/Met
(N = 40)

Met/Met
(N = 16)

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Onset of habitual drinking

15

3.51

16

3.96

15

2. 12

16

3.17

16

3.89

18

5.51

Onset of pathological drinking

25

4.50

25

9.23

25

0.00

28

8.30

30

10.31

27

10.01

Admission to alcohol treatment

35

4.04

29

9.06

40.0

1.41

40

9.01

43

10.01

36

8.37
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Table 4. Comparisons of variables of alcohol consumption among the 3 subgroups of the COMT genotype in female and male alcoholic
subjects (*not available for statistical analyses).
Female alcoholics (N = 10)

Male alcoholics (N = 100)

COMT genotype
Variables

COMT genotype

Val/Val
(N = 3)
n (%)

Val/Met
(N = 5)
n (%)

Met/Met
(N = 2)
n (%)

Drinking ≤10 unit (n = 35)

2 (50.0%)

1 (25.0%)

1 (25.0%)

Drinking >10 unit (n = 75)

1 (16.7%)

4 (66.7%)

1 (16.7%)

P

P

Val/Val
(N = 44)
n (%)

Val/Met
(N = 40)
n (%)

Met/Met
(N = 16)
n (%)

0.560

20 (64.5%)

7 (22.6%)

4(12.9%)

0.610

0.582

24 (34.8%)

33 (47.8%)

12 (17.4%)

0.272

Drinking amount

Drinking frequency
1-2 times/month (n = 1)

0 (0%)

0 (0%)

0 (0%)

*

0 (0%)

1 (100.0%)

0 (0%)

*

1-2 times/week (n = 3)

1 (100.0%)

0 (0%)

0 (0%)

*

1 (50.0%)

0 (0%)

1 (50.0%)

*

Every day (n = 106)

2 (22.2%)

5 (55.6%)

2 (22.2%)

0.734

43 (44.3%)

39 (40.2%)

15 (15.5%)

0.421

Table 5. Comparisons of variables of family history of psychiatric disorders, alcohol dependence, and smoking/drug abuse among the
3 subgroups of the COMT genotype in female and male alcoholic subjects (*not available for statistical analyses).
Female alcoholics (N = 10)

Male alcoholics (N = 100)

COMT genotype
Variables

COMT genotype

Val/Val
(N = 3)
n (%)

Val/Met
(N = 5)
n (%)

Met/Met
(N = 2)
n (%)

3 (30.0%)

5 (50.0%)

2 (20.0%)

Drug abusers (n = 4)

0 (0%)

0 (0%)

Smokers + drug abusers (n = 9)

0 (0%)

P

Val/Val
(N = 44)
n (%)

Val/Met
(N = 40)
n (%)

Met/Met
(N = 16)
n (%)

0.487

39 (44.9%)

35 (40.3%)

13 (14.8%)

0.246

0 (0%)

*

1 (25.0%)

1 (25.0%)

2 (50.0%)

0.511

0 (0%)

0 (0%)

*

4 (44.4%)

4 (44.4%)

1 (11.2%)

0.489

3 (37.5%)

3 (37.5%)

2 (25.0%)

0.625

42 (47.7%)

33 (37.5%)

13 (14.8%)

0.312

First-degree (n = 10)

0 (0%)

1 (100.0%)

0 (0%)

*

2 (22.2%)

6 (66.7%)

1 (11.1%)

0.587

Second-degree (n = 4)

0 (0%)

1 (100.0%)

0 (0%)

*

0 (0%)

1 (33.3%)

2 (66.6%)

*

0 (0%)

2 (100.0%)

0 (0%)

*

19 (50.0%)

12 (31.6%)

7 (18.4%)

0.645

1 (100.0%)

0 (0%)

0 (0%)

*

7 (35.0%)

7 (35.0%)

6 (30.0%)

0.521

0 (0%)

2 (100.0%)

0 (0%)

*

6 (50.0%)

6 (50.0%)

0 (0%)

0.475

2 (40.0%)

1 (20.0%)

2 (40.0%)

0.625

12 (40.0%)

15 (50.0%)

3 (10.0%)

0.254

No cases (n = 101)

3 (37.5%)

5 (62.5%)

0 (0%)

0.654

40 (43.0%)

38 (40.9%)

15 (16.1%)

0.126

First-degree (n = 4)

0 (0%)

0 (0%)

2 (100.0%)

*

2 (100.0%)

0 (33.3%)

0 (0%)

*

Second-degree (n = 5)

0 (0%)

0 (0%)

0 (0%)

*

2 (40.0%)

2 (40.0%)

1 (20.0%)

0.752

P

Smoking/drug abuse
Smokers (n = 97)

Relatives with psychiatric disorders
No cases (n = 96)

Relatives with alcohol dependence
No cases (n = 40)
First-degree (n = 21)
Second-degree (n = 14)
Many family members (n = 35)
Relatives with drug abuse
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pointed out that because the study had less than the
desired power (<0.800), a difference was less likely
to be detected, so it is not possible to conclude that
the presented data did not confirm the significant
association in the frequency of COMT Val108/Met
polymorphism for the development of alcoholism
in Turkish subjects. Therefore, to find a possible
association between the Met allele and alcoholism,
this study should be evaluated again with an enlarged
study group. Moreover, the deviation from the HardyWeinberg equilibrium found in the control group is
not presently clear.
The results are in contrast with data of previous
studies, which do support the hypothesis that the
functional COMT Val108/Met polymorphism is
linked to alcoholism (5,16-18). Unfortunately, there
are actually more studies that either link the highactivity Val allele with alcoholism (19,22,23), or do
not support this hypothesis at all, like this study
(2,14,15,24,25). This is a common problem with
genetic studies of multifactorial diseases, because
environmental factors also contribute excessively to
their development. This was shown in a study in which
the high-activity Val allele was found to be linked with
alcoholism and smoking, and the authors claimed
that the low-activity Met allele could confer both
risk and resilience to alcoholism in different drinking
environments (22,26). However, it should also be
mentioned that the frequency of the polymorphic
COMT Met allele in this study was found to be
similar to the frequencies of other Turkish groups
(27,28). Studies of an Asian population, like in Japan
and Korea, had nearly the same number of alcoholic
cases as the present study and found similar COMT
allele frequencies (2,25). Since ethnic differences
exist in COMTVal108/158Met polymorphism (29),
variations in the frequencies of functionally different
COMT alleles are also seen in alcoholism. As a result,
it is thought that the genotype distribution and
allele frequency of the COMT Val108/158Met gene
polymorphism in our study and control groups reflect
their real distribution in the Turkish population.
In this study, the ratio of female to male alcoholic
subjects was 1:10.. The reason for this discrepancy is
that in Turkey, alcohol usage is not very common,
and therefore, it is even less common among women.
A wide-screen study that evaluated the prevalence

of alcohol addiction among males and females in
Turkey reported 1.7% for men and 0.1% for women
(30). The Turkish population includes many different
ethnic groups and a clear subdivision cannot be
made. When considering ethnic differences, Turkish
alcoholics may resemble more the Asian than the
European Caucasian population, since no association
between alcoholism and the COMT Val108/Met
polymorphism was found in the Asian population
(2,24) in contrast to the European Caucasian
population (5,16,18).
To further dissect the environmental factors
that could contribute to alcoholism, the social
backgrounds of the study group were analyzed.
Interestingly, most of the subjects had a good social
background (i.e. were well educated, employed, and
married), and we did not observe any significant
differences among the 3 subgroups of the COMT
genotype in female and male alcoholic subjects.
This was also in good agreement with the results of
previous studies (2,16).
The variables related to age among the 3
subgroups of the COMT genotype in the study group
were then analyzed. Among the female and male
alcoholic subjects, ages at the onset of habitual and
pathological drinking were very similar, whereas
ages on admission for alcohol treatment were a
bit higher in the male alcoholic subjects than the
females. Nevertheless, no significant differences were
observed, and these results were in good agreement
with the results of previous studies (24,31).
In a study in which the low-activity Met allele
of the COMT polymorphism was associated with
alcohol consumption among social drinkers, the ageadjusted weekly alcohol consumption was higher in
the subjects with the low-activity COMT genotype
(16). To address this question in the present study
group, and to find out if we might see any differences
in alcohol consumption among the 3 subgroups of
the COMT genotype, we compared the drinking
amount and frequencies of the subjects, but found
no association between any of these variables and the
COMT genotype in the female and male alcoholic
subjects.
The high-activity Val genotype and allele were
shown to be more prevalent in alcoholic smokers,
polysubstance abusers, and individuals meeting
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the DSM-III-R substance abuse criteria than in the
controls (2,22,23). No significant difference among
the different COMT genotypes between the alcoholic
and control groups was found in the present study.
Munafo et al. reported that there was an
association between the COMT Val108/158Met
genotype and cigarette smoking in pregnant women
(32), and Nedic et al. found an association between
COMT polymorphism and smoking in healthy
Caucasian subjects (33). Similar results were found in
our violent drunk or sober alcoholics, as the Val/Val
genotype and Val allele were slightly more prevalent
in these subjects; however, this difference did not
reach a level of statistical significance. Ishiguro et al.
found that there was an association between either the
high- or low-activity polymorphism of the catecholO-methyltransferase gene and alcoholism (2), yet on
the other hand, similar to our results, no association
was found between the Val allele and alcoholism
(24). In a metaanalysis of twin studies, it was shown
that the heritability of all addictive substances ranges
from 40% to 60%. In the same study, the heritability
for alcoholism derived from nearly 10,000 twin pairs
was 50% (34). Thus, genetic and environmental
factors are almost equally important in alcoholism
risk. In a family-based and case-control study of
some gene polymorphisms in alcohol dependence,
the COMT Val108/158Met polymorphism revealed
adequate transmissions of alleles to the affected

offspring (14). To evaluate whether there is an
association between the COMT polymorphism and
the family history of psychiatric disorders, alcohol
dependence, and drug abuse, the 3 subgroups of the
COMT genotype were investigated. An indication of
the heritability of alcoholism was also shown, with
64% of the subjects having at least 1 alcoholic relative
in their family, but again, no significant association
between the heritability of alcoholism and the COMT
polymorphism was observed.
In conclusion, the present study does not support
the hypothesis that the Met (A) allele of COMT
is associated with alcoholism, due to the lack of
statistical power; therefore, the study should be
repeated in larger groups to find a possible association.
Moreover, no association was found between the
COMT Val108/158Met polymorphism and some
environmental and genetic factors that are known
to be involved in the development of alcoholism.
However, it would be interesting to further investigate
this particular COMT polymorphism together with
alcoholism.
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